Home> Announcements> International topics> Trilateral Cooperation (JPO-EPO-USPTO)> Trilateral Project 24.1-Biotechnology> Trilateral Project 24.1-Biotechnology 117
Main content starts here.
It is necessary for the applicant to make a clear assurance that the microorganism will be deposited on or before payment of the Issue Fee (see 37 C.F.R. Sec. 1.809(c)).